$30.01
2.35% today
NYSE, Aug 12, 09:14 pm CET
ISIN
US90328M1071
Symbol
USNA

USANA Health Sciences, Inc. Stock price

$29.32
-3.67 11.12% 1M
-1.65 5.33% 6M
-6.57 18.31% YTD
-8.14 21.73% 1Y
-39.67 57.50% 3Y
-53.49 64.59% 5Y
-51.62 63.77% 10Y
+5.37 22.40% 20Y
NYSE, Closing price Mon, Aug 11 2025
+0.47 1.63%
ISIN
US90328M1071
Symbol
USNA

Key metrics

Basic
Market capitalization
$535.7m
Enterprise Value
$384.4m
Net debt
positive
Cash
$151.3m
Shares outstanding
18.3m
Valuation (TTM | estimate)
P/E
15.9 | 11.0
P/S
0.6 | 0.6
EV/Sales
0.4 | 0.4
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
71.1%
Return on Equity
7.9%
ROCE
9.2%
ROIC
6.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$899.2m | $973.6m
EBITDA
$91.3m | $112.2m
EBIT
$56.2m | $79.7m
Net Income
$34.1m | $48.6m
Free Cash Flow
$-152.4m
Growth (TTM | estimate)
Revenue
2.8% | 13.9%
EBITDA
-6.4% | 26.7%
EBIT
-33.4% | 20.1%
Net Income
-38.0% | 15.7%
Free Cash Flow
-357.1%
Margin (TTM | estimate)
Gross
79.9%
EBITDA
10.2% | 11.5%
EBIT
6.3%
Net
3.8% | 5.0%
Free Cash Flow
-16.9%
More
EPS
$1.8
FCF per Share
$-8.3
Short interest
7.4%
Employees
2k
Rev per Employee
$500.0k
Show more

Is USANA Health Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

USANA Health Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a USANA Health Sciences, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a USANA Health Sciences, Inc. forecast:

Hold
50%
Sell
50%

Financial data from USANA Health Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
899 899
3% 3%
100%
- Direct Costs 180 180
7% 7%
20%
719 719
2% 2%
80%
- Selling and Administrative Expenses 663 663
6% 6%
74%
- Research and Development Expense - -
-
-
91 91
6% 6%
10%
- Depreciation and Amortization 35 35
167% 167%
4%
EBIT (Operating Income) EBIT 56 56
33% 33%
6%
Net Profit 34 34
38% 38%
4%

In millions USD.

Don't miss a Thing! We will send you all news about USANA Health Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

USANA Health Sciences, Inc. Stock News

Neutral
PRNewsWire
8 days ago
SALT LAKE CITY , Aug. 4, 2025 /PRNewswire/ -- With August marking National Wellness Month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is encouraging people to embrace small daily habits that lead to lasting wellness mentally, physically, and emotionally. "Wellness isn't something you check off a list; it's a rhythm you live," said Guest, author of All the Right Reaso...
Positive
Seeking Alpha
19 days ago
USANA Health Sciences is resurfacing as an idea after a strong Q2 report. The direct selling business has continued to struggle with a decline in sales and active customers. A segment turnaround remains uncertain. The previous Hiya acquisition's potential is clearly showing. Operational expansion underlines massive long-term potential for USANA.
Neutral
Seeking Alpha
20 days ago
USANA Health Sciences, Inc. (NYSE:USNA ) Q2 2025 Earnings Conference Call July 23, 2025 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Brent L. Neidig - Chief Commercial Officer G.
More USANA Health Sciences, Inc. News

Company Profile

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group. The Optimizers Nutritionals category consists of targeted supplements that support cardiovascular health, skeletal and structural health, and digestive health. The Foods Nutritionals category includes low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense-beautiful science includes premium, science-based, personal care products that support healthy skin and hair by providing topical nourishment, moisturization, and protection. The firm's brand include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Jim Brown
Employees 1,700
Founded 1992
Website www.usana.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today